Redmile Group leads Series B round for Scioderm

Scioderm, a Durham, NC-based pharmaceutical firm, has closed $20 million in Series B funding. Redmile Group led the round with participation from other investors that included Morganthaler Ventures and Technology Partners. J.P. Morgan Securities was the placement agent on the transaction.

North AmericaUSBriefs